4,5 Immune Checkpoint Inhibitors Immune checkpoint inhibitors are the current standard of care for the treatment of several types of cancer, including solid-organ and hematologic malignancies
2017 to 2022 Saw More Than Doubling in Use of GLP-1 Receptor Agonists MONDAY, July 20, 2026 -- From 2017 to 2022, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) more than doubled, according to a study published online July 17 in
Slows digestion and carbohydrate absorption
Whether selecting a current product from our catalog or seeking engineering assistance for your application, you can talk to our customer service center about your sourcing requirements
Chronic abuse is associated with cognitive impairments, including memory and attention deficits, psychotic-like symptoms (hallucinations and delusions), and motor dysfunction (Morgan et al., 2004)